Education
About Us
Working with TipRanks
Follow Us
HeraMED Ltd. (DE:1I4)
FRANKFURT:1I4
Total Valuation
HeraMED Ltd. has a market cap or net worth of €20.53M. The enterprise value is €5.17M.
Market Cap€20.53M
Enterprise Value€5.17M
Share Statistics
HeraMED Ltd. has 1,042,052,700 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,042,052,700
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
HeraMED Ltd.’s return on equity (ROE) is -1.98 and return on invested capital (ROIC) is -216.36%.
Return on Equity (ROE)-1.98
Return on Assets (ROA)-1.22
Return on Invested Capital (ROIC)-216.36%
Return on Capital Employed (ROCE)-2.62
Revenue Per Employee10.00T>
Profits Per Employee-10.00T>
Employee Count―
Asset Turnover0.08
Inventory Turnover0.24
Valuation Ratios
The current PE Ratio of HeraMED Ltd. is ―. HeraMED Ltd.’s PEG ratio is 0.03.
PE Ratio―
PS Ratio29.19
PB Ratio3.84
Price to Fair Value3.84
Price to FCF-2.21
Price to Operating Cash Flow-7.26
PEG Ratio0.03
Income Statement
In the last 12 months, HeraMED Ltd. had revenue of 225.49K and earned -3.40M in profits. Earnings per share was -0.01.
Revenue225.49K
Gross Profit135.29K
Operating Income-5.57M
Pretax Income-3.40M
Net Income-3.40M
EBITDA-3.35M
Earnings Per Share (EPS)-0.01
Cash Flow
In the last 12 months, operating cash flow was -2.58M and capital expenditures 36.37K, giving a free cash flow of -2.55M billion.
Operating Cash Flow-2.58M
Free Cash Flow-2.55M
Free Cash Flow per Share>-0.01
Dividends & Yields
HeraMED Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.54
52-Week Price Change100.00%
50-Day Moving Average0.02
200-Day Moving Average―
Relative Strength Index (RSI)47.08
Average Volume (3m)152.85K
Important Dates
HeraMED Ltd. upcoming earnings date is Mar 4, 2026, TBA (Confirmed).
Last Earnings DateAug 28, 2025
Next Earnings DateMar 4, 2026
Ex-Dividend Date―
Financial Position
HeraMED Ltd. as a current ratio of 3.52, with Debt / Equity ratio of 0.00%
Current Ratio3.52
Quick Ratio2.95
Debt to Market Cap0.02
Net Debt to EBITDA0.69
Interest Coverage Ratio-115.30
Taxes
In the past 12 months, HeraMED Ltd. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
HeraMED Ltd. EV to EBITDA ratio is -1.27, with an EV/FCF ratio of -1.43.
EV to Sales18.93
EV to EBITDA-1.27
EV to Free Cash Flow-1.43
EV to Operating Cash Flow-1.43
Balance Sheet
HeraMED Ltd. has €628.17K in cash and marketable securities with €0.00 in debt, giving a net cash position of €628.17K billion.
Cash & Marketable Securities€628.17K
Total Debt€0.00
Net Cash€628.17K
Net Cash Per Share<€0.01
Tangible Book Value Per Share<€0.01
Margins
Gross margin is 58.35%, with operating margin of -2469.41%, and net profit margin of -1507.04%.
Gross Margin58.35%
Operating Margin-2469.41%
Pretax Margin-1507.04%
Net Profit Margin-1507.04%
EBITDA Margin-1485.28%
EBIT Margin-1496.29%
Analyst Forecast
The average price target for HeraMED Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―